Sham Shridhar Nikam

Person

Ann Arbor, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Phenylalkyl and pyridylalkyl piperazine derivatives
- Patent number 7,101,886
- Issue date Sep 5, 2006
- Warner-Lambert Company
- Stephen Sung Yong Cho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclohexylamine derivative as subtype selective NMDA receptor antag...
- Patent number 6,919,377
- Issue date Jul 19, 2005
- Warner-Lambert Company LLC
- Russell Joseph Deorazio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclohexylamine derivatives as subtype selective N-Methyl-D-Asparta...
- Patent number 6,828,341
- Issue date Dec 7, 2004
- Warner-Lambert Company
- Russell Joseph DeOrazio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
- Patent number 6,794,402
- Issue date Sep 21, 2004
- Warner-Lambert Company
- Sham Shridhar Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclohexylamine derivatives as subtype selective nmda receptor anta...
- Patent number 6,765,022
- Issue date Jul 20, 2004
- Warner-Lambert Company
- Russell Joseph Deorazio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
- Patent number 6,683,101
- Issue date Jan 27, 2004
- Warner-Lambert Company
- Russell Joseph Deorazio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives as subtype selective N-Methyl-D-Aspartate an...
- Patent number 6,642,256
- Issue date Nov 4, 2003
- Warner-Lambert Company LLC
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Conformationally semi-constrained quinoxaline 2,3-diones as neuropr...
- Patent number 6,455,698
- Issue date Sep 24, 2002
- Warner-Lambert Company
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quenching reagents for solution phase synthesis
- Patent number 6,417,396
- Issue date Jul 9, 2002
- Sham Nikam
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Quenching reagents for solution phase synthesis
- Patent number 6,395,930
- Issue date May 28, 2002
- Warner-Lambert
- Sham Nikam
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Conformationally semi-constrained quinoxaline 2,3-diones as neuropr...
- Patent number 6,340,758
- Issue date Jan 22, 2002
- Warner-Lambert Company
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amide derivatives of substituted quinoxaline 2,3-diones as glutamat...
- Patent number 6,268,366
- Issue date Jul 31, 2001
- Warner-Lambert Company
- Sham Shridhar Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amide derivatives of substituted quinoxaline 2, 3-diones as glutama...
- Patent number 6,191,134
- Issue date Feb 20, 2001
- Warner-Lambert Company
- Sham Shridhar Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Urea and thiourea derivatives of substituted quinoxaline 2,3-diones...
- Patent number 6,172,065
- Issue date Jan 9, 2001
- Warner-Lambert Company
- Sham Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quenching reagents for solution phase synthesis
- Patent number 6,121,488
- Issue date Sep 19, 2000
- Warner-Lambert Company
- Sham Nikam
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Cyclic amine derivatives of substituted quinoxaline 2,3-diones as g...
- Patent number 6,110,911
- Issue date Aug 29, 2000
- Warner-Lambert Company
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide derivatives of substituted quinoxaline 2,3-diones as gl...
- Patent number 6,096,744
- Issue date Aug 1, 2000
- Warner-Lambert Company
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic quinoxaline derivatives as neuroprotective agents
- Patent number 6,063,774
- Issue date May 16, 2000
- Warner-Lambert Company
- Sham Nikam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted quinoxaline-2-ones as glutamate receptor antagonists
- Patent number 6,015,800
- Issue date Jan 18, 2000
- Warner-Lambert Company
- Sham Shridhar Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amine derivatives of substituted quinoxaline 2,3-diones as g...
- Patent number 5,874,426
- Issue date Feb 23, 1999
- Warner-Lambert Company
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolines as inhibitors of endothelin converting enzyme
- Patent number 5,773,444
- Issue date Jun 30, 1998
- Warner-Lambert Company
- Kyunghye Ahn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamate inhibitors of endothelin converting enzyme
- Patent number 5,663,296
- Issue date Sep 2, 1997
- Warner-Lambert Company
- Annette Marian Doherty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolines as inhibitors of endothelin converting enzyme
- Patent number 5,658,902
- Issue date Aug 19, 1997
- Warner-Lambert Company
- Kyunghye Ahn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alkyl amine derivatives of substituted quinoxaline 2,3-diones as gl...
- Patent number 5,654,303
- Issue date Aug 5, 1997
- Warner-Lambert Company
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino acid derivatives of substituted quinoxaline 2,3-dione derivat...
- Patent number 5,614,508
- Issue date Mar 25, 1997
- Warner-Lambert Company
- Sham Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chiral ethyl [6-amino-4-[[12-(methoxymethylamino)-1-methyl-2-oxoeth...
- Patent number 5,484,930
- Issue date Jan 16, 1996
- Warner-Lambert Company
- Om P. Goel
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Heterocyclic substituted indane derivatives and related compounds f...
- Publication number 20050282819
- Publication date Dec 22, 2005
- James M. Graham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenylalkyl and pyridylalkyl piperazine derivatives
- Publication number 20040186108
- Publication date Sep 23, 2004
- Stephen Sung Yong Cho
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic substituted piperazines for the treatment of schizophr...
- Publication number 20040138230
- Publication date Jul 15, 2004
- Tonja Lynn Andreana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic cyclohexylamines and their use as nmda receptor antagonists
- Publication number 20030236252
- Publication date Dec 25, 2003
- Sham Shridhar Nikam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexylamine derivative as subtype selective nmda receptor antag...
- Publication number 20030236286
- Publication date Dec 25, 2003
- Russell Joseph Deorazio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic cyclohexylamines and their use as nmda receptor antagonists
- Publication number 20030232810
- Publication date Dec 18, 2003
- Russell Joseph Deorazio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexylamine derivatives as subtype selective nmda receptor anta...
- Publication number 20030225164
- Publication date Dec 4, 2003
- Russell Joseph Deorazio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine derivatives as subtype selective N-methyl-D-aspartate an...
- Publication number 20030018021
- Publication date Jan 23, 2003
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexylamine derivatives as subtype selective N-Methyl-D-Asparta...
- Publication number 20030004212
- Publication date Jan 2, 2003
- Russell Joseph DeOrazio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Conformationally semi-constrained quinoxaline 2,3-diones as neuropr...
- Publication number 20020065415
- Publication date May 30, 2002
- Brian Edward Kornberg
- C07 - ORGANIC CHEMISTRY

Sham Shridhar Nikam

Person

Patents Grantslast 30 patents

Phenylalkyl and pyridylalkyl piperazine derivatives

Cyclohexylamine derivative as subtype selective NMDA receptor antag...

Cyclohexylamine derivatives as subtype selective N-Methyl-D-Asparta...

Bicyclic cyclohexylamines and their use as NMDA receptor antagonists

Cyclohexylamine derivatives as subtype selective nmda receptor anta...

Bicyclic cyclohexylamines and their use as NMDA receptor antagonists

Piperidine derivatives as subtype selective N-Methyl-D-Aspartate an...

Conformationally semi-constrained quinoxaline 2,3-diones as neuropr...

Quenching reagents for solution phase synthesis

Quenching reagents for solution phase synthesis

Conformationally semi-constrained quinoxaline 2,3-diones as neuropr...

Amide derivatives of substituted quinoxaline 2,3-diones as glutamat...

Amide derivatives of substituted quinoxaline 2, 3-diones as glutama...

Urea and thiourea derivatives of substituted quinoxaline 2,3-diones...

Quenching reagents for solution phase synthesis

Cyclic amine derivatives of substituted quinoxaline 2,3-diones as g...

Sulfonamide derivatives of substituted quinoxaline 2,3-diones as gl...

Tricyclic quinoxaline derivatives as neuroprotective agents

Substituted quinoxaline-2-ones as glutamate receptor antagonists

Cyclic amine derivatives of substituted quinoxaline 2,3-diones as g...

Quinazolines as inhibitors of endothelin converting enzyme

Hydroxamate inhibitors of endothelin converting enzyme

Quinazolines as inhibitors of endothelin converting enzyme

Alkyl amine derivatives of substituted quinoxaline 2,3-diones as gl...

Amino acid derivatives of substituted quinoxaline 2,3-dione derivat...

Chiral ethyl [6-amino-4-[[12-(methoxymethylamino)-1-methyl-2-oxoeth...

Patents Applicationslast 30 patents

Heterocyclic substituted indane derivatives and related compounds f...

Phenylalkyl and pyridylalkyl piperazine derivatives

Heterocyclic substituted piperazines for the treatment of schizophr...

Bicyclic cyclohexylamines and their use as nmda receptor antagonists

Cyclohexylamine derivative as subtype selective nmda receptor antag...

Bicyclic cyclohexylamines and their use as nmda receptor antagonists

Cyclohexylamine derivatives as subtype selective nmda receptor anta...

Piperidine derivatives as subtype selective N-methyl-D-aspartate an...

Cyclohexylamine derivatives as subtype selective N-Methyl-D-Asparta...

Conformationally semi-constrained quinoxaline 2,3-diones as neuropr...